Skip to content

ALK+

Anaplastic lymphoma kinase (ALK) positive; refers to the mutation or rearrangement in the ALK+ gene. See ALK+ NSCLC.

Roche New Zealand
Legal Statement
Privacy Statement
Glossary
Contact Us

© 2023, Roche Products (New Zealand) Limited, Auckland. For more information about Roche, please visit www.roche.co.nz. This site is intended for New Zealand audiences. Access to this site is subject to the terms in our Legal and Privacy Statement. You accept these terms by continuing to access this site.

M-NZ-000000084-V.19/MR10745/DEC2024 This site was last updated December 2024.

Thank you for visiting our site.

You are about to leave the site to one that is not affiliated to Roche Products (New Zealand) Ltd. Roche Products (New Zealand) does not endorse or control, the content of any linked websites and if you click OK, you agree that Roche has no responsibility or duty to you for anything that happens to you as a result. If the linked site is outside New Zealand’s jurisdiction, the information may not be consistent with New Zealand’s legislation, advertising codes or the relevant New Zealand registered Data Sheet. Please refer to the Data Sheet or Consumer Medicine Information on the Medsafe website for product information applicable to New Zealand.

Click OK to continue.

Ok Continue Close